SAE serious adverse event
Showing 1 - 25 of >10,000
Serious Adverse Event in Emergency Department With dysKAlemia,
Recruiting
- Emergencies
-
Metz, FranceCHR Metz-Thionville/Hopital de Mercy
Mar 28, 2023
Serious Adverse Events Within the AFNET
Completed
- Atrial Fibrillation
- +4 more
-
Brandenburg, GermanyStaedt. Klinikum, Department of Cardiology
Sep 18, 2020
Continuous Monitoring of Vital Signs at Home (WARD HOME II)
Recruiting
- Vital Sign Monitoring
- +2 more
- Continuously monitoring
-
Copenhagen, NV, DenmarkBispebjerg Hospital
Oct 4, 2023
GENE SEQUENCING AS A STRATEGY FOR IDENTIFYING GENETIC FACTORS
Recruiting
- Covid-19 Vaccination Serious Adverse Events
-
Rio De Janeiro, BrazilUnidade de Ensaios Clínicos para Imunobiológicos (UECI)
Nov 23, 2022
Healthy Volunteers Trial in Dhaka (ShigETEC live, attenuated, oral vaccine, Placebo)
Not yet recruiting
- Healthy Volunteers
- ShigETEC live, attenuated, oral vaccine
- Placebo
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Diseases Research, Banglades
Aug 3, 2023
Hand, Foot and Mouth Disease Trial (EV71 Vaccine)
Not yet recruiting
- Hand, Foot and Mouth Disease
- EV71 Vaccine
- (no location specified)
Nov 17, 2023
Athletic Performance Trial in Cornelius (Clinical Investigation on Enhanced Sports Nutrition and Performance Activities by
Recruiting
- Athletic Performance
- Clinical Investigation on Enhanced Sports Nutrition and Performance Activities by Prodovite VMP35 Supplement
- Broad Spectrum Safety
-
Cornelius, North CarolinaChampions Sports Performance & Hardcore Serious Fitness
May 5, 2021
Viral Infection COVID-19 Trial in Saint Petersburg, (Aterixen)
Not yet recruiting
- Viral Infection COVID-19
-
Saint Petersburg,, Russian FederationLimited Liability Company "Research Center Eco-Safety"
Oct 23, 2023
NSCLC Trial in Guangzhou (PEF, Anti-PD-1 mAb)
Recruiting
- NSCLC
- PEF
- Anti-PD-1 monoclonal antibody
-
Guangzhou, Guangdong, ChinaThe first Affiliated Hospital of Guangzhou Medical University
Aug 3, 2023
Evaluation of Growth Hormone in Children in China(CGLS)
Recruiting
- Childhood Short Stature
- Polvethylene glycol recombinant human growth hormone injection (PEG-rhGH) or recombinanthuman growth hormone injection (rhGH)
-
Wuhan, Hubei, ChinaTongjiHospital
Oct 31, 2023
Ebola Virus Disease Trial in Boende (Ad26.ZEBOV vaccine)
Completed
- Ebola Virus Disease
- Ad26.ZEBOV vaccine
-
Boende, Province De La Tshuapa, Congo, The Democratic Republic of theHôpital Général de Référence de Boende
Jan 3, 2023
Biosimilars of Rituximab in ANCA-associated Vasculitis Compared
Recruiting
- ANCA-associated Vasculitis
- +2 more
-
Calgary, Alberta, Canada
- +8 more
Jan 27, 2023
Acute Otitis Media (AOM) Trial in Thailand (V114, Pediatric vaccines)
Active, not recruiting
- Acute Otitis Media (AOM)
- V114
- Pediatric vaccines
-
Bangkok, Krung Thep Maha Nakhon, Thailand
- +12 more
Aug 17, 2022
COVID-19 Trial in Jakarta, Bandung (Standard of Care + Quinine Sulfate, Standard of Care)
Recruiting
- COVID-19
- Standard of Care + Quinine Sulfate
- Standard of Care
-
Jakarta, DKI Jakarta, Indonesia
- +1 more
Apr 10, 2023
Grade 1 Glioma, Mixed Glio-neuronal Tumors, Pleomorphic Xanthoastrocytoma Trial in Strasbourg (Trametinib, Vinblastine)
Recruiting
- Grade 1 Glioma
- +2 more
-
Strasbourg, FranceCHU Strasbourg - France
Jul 7, 2022
Metastatic Lung Non-Small Cell Carcinoma, EGFR T790M Trial in Seoul (Lazertinib)
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- EGFR T790M
-
Seoul, Korea, Republic ofSamsung Medical Center
May 18, 2022
Brain Injury Traumatic Severe (Diagnosis), Coma, Consciousness, Level Altered Trial in Boston (Methylphenidate)
Recruiting
- Brain Injury Traumatic Severe (Diagnosis)
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Feb 1, 2022
COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)
Not yet recruiting
- COVID-19
- Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
- Placebo
- (no location specified)
Sep 22, 2023
Intraventricular Hemorrhage of Prematurity Trial (MLT+EPO, Placebo)
Not yet recruiting
- Intraventricular Hemorrhage of Prematurity
- MLT+EPO
- Placebo
- (no location specified)
Jan 5, 2023
Advanced Liver Cancer Trial (OH2 injection)
Not yet recruiting
- Advanced Liver Cancer
- OH2 injection
- (no location specified)
Jan 29, 2023
Nesina® Tablet Monotherapy or Combination Therapy in Type 2
Completed
- Type 2 Diabetes Mellitus
- Alogliptin Benzoate
-
Andong, Korea, Republic of
- +22 more
Mar 31, 2022
CNS Tumors Trial in Beijing (OH2 injection)
Recruiting
- Central Nervous System Tumors
- OH2 injection
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Feb 2, 2023
Primary Hepatocellular Carcinoma Trial (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), camrelizumab for
Not yet recruiting
- Primary Hepatocellular Carcinoma
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
- camrelizumab for Injection
- (no location specified)
Nov 13, 2023